Adrenergic beta-Antagonists
"Adrenergic beta-Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
| Descriptor ID |
D000319
|
| MeSH Number(s) |
D27.505.519.625.050.200.200 D27.505.696.577.050.200.200
|
| Concept/Terms |
Adrenergic beta-Antagonists- Adrenergic beta-Antagonists
- Adrenergic beta Antagonists
- beta-Antagonists, Adrenergic
- beta-Adrenergic Receptor Blockaders
- Blockaders, beta-Adrenergic Receptor
- Receptor Blockaders, beta-Adrenergic
- beta Adrenergic Receptor Blockaders
- beta-Adrenergic Blockers
- Blockers, beta-Adrenergic
- beta Adrenergic Blockers
- beta-Blockers, Adrenergic
- Adrenergic beta-Blockers
- beta Blockers, Adrenergic
- Adrenergic beta-Receptor Blockaders
- Adrenergic beta Receptor Blockaders
- Blockaders, Adrenergic beta-Receptor
- beta-Receptor Blockaders, Adrenergic
- beta-Adrenergic Blocking Agents
- Agents, beta-Adrenergic Blocking
- Blocking Agents, beta-Adrenergic
- beta Adrenergic Blocking Agents
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-Antagonists".
This graph shows the total number of publications written about "Adrenergic beta-Antagonists" by people in this website by year, and whether "Adrenergic beta-Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 2 | 0 | 2 |
| 1996 | 3 | 1 | 4 |
| 1997 | 0 | 3 | 3 |
| 1998 | 1 | 1 | 2 |
| 1999 | 5 | 1 | 6 |
| 2000 | 1 | 2 | 3 |
| 2001 | 0 | 2 | 2 |
| 2002 | 2 | 4 | 6 |
| 2003 | 9 | 3 | 12 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 3 | 5 |
| 2006 | 1 | 5 | 6 |
| 2007 | 2 | 3 | 5 |
| 2008 | 0 | 4 | 4 |
| 2009 | 1 | 2 | 3 |
| 2010 | 3 | 6 | 9 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 4 | 3 | 7 |
| 2014 | 2 | 5 | 7 |
| 2015 | 2 | 1 | 3 |
| 2016 | 4 | 1 | 5 |
| 2017 | 0 | 3 | 3 |
| 2018 | 2 | 5 | 7 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 3 | 2 | 5 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenergic beta-Antagonists" by people in Profiles.
-
Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Aliment Pharmacol Ther. 2023 Mar; 57(5):454-463.
-
Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol. Ann Otol Rhinol Laryngol. 2023 Mar; 132(3):332-340.
-
Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment Guidelines. Hypertension. 2022 02; 79(2):338-348.
-
Letter: Confounders and outcomes in studies of beta-blockers in liver disease-role of PPIs? Authors' reply. Aliment Pharmacol Ther. 2021 07; 54(1):91.
-
Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma. JAMA Dermatol. 2021 05 01; 157(5):566-572.
-
Editorial: non-selective beta blockers-in and out of circulation. Authors' reply. Aliment Pharmacol Ther. 2021 03; 53(5):634-635.
-
Carvedilol Does Not Improve Exercise Performance in Fontan Patients: Results of a Crossover Trial. Pediatr Cardiol. 2021 Apr; 42(4):934-941.
-
Non-selective beta-blocker use in cirrhotic patients is associated with a reduced likelihood of hospitalisation for infection. Aliment Pharmacol Ther. 2021 02; 53(3):418-425.
-
Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. Am J Med. 2020 10; 133(10):1187-1194.
-
An Update: Portal Hypertensive Gastropathy and Colopathy. Clin Liver Dis. 2019 11; 23(4):643-658.